US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.750
  • +0.076+11.33%
Close Jan 7 16:00 ET
  • 0.744
  • -0.006-0.83%
Post 20:01 ET
67.92MMarket Cap-0.41P/E (TTM)

Verrica Pharmaceuticals Key Stats

Verrica Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 2.109M --
-- 2024/Q4 -- / 1.302M --
-- 2024/Q3 -1.781M / 5.262M --
Aug 14, 2024 2024/Q2 5.177M / 4.550M --
May 13, 2024 2024/Q1 3.826M / 2.651M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.109M--
--2024/Q4-- / 1.302M--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--

Unlock Free Earnings Estimates

Verrica Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 6, 2025

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data